| $337M | ||
| $259M | ||
| $100M | ||
| $79M | ||
| $60M | ||
| $58M |
Buys | $0 | 0 | 0 |
Sells | $50,324,664 | 43 | 100 |
| Yu Jonathan Yen-Wen | Chief Operating Officer | 0 | $0 | 1 | $87,874 | $-87,874 |
| Stephenson Pamela | Chief Commercial Officer | 0 | $0 | 1 | $171,217 | $-171,217 |
| Franchi Jean M. | Chief Financial Officer | 0 | $0 | 4 | $510,511 | $-510,511 |
| White William Richard | director | 0 | $0 | 6 | $670,218 | $-670,218 |
| Khara Rahul | Chief Legal Officer | 0 | $0 | 3 | $950,599 | $-950,599 |
| Savage William Jacob | Chief Medical Officer | 0 | $0 | 8 | $2.3M | $-2.3M |
| Quisel John D | Chief Executive Officer | 0 | $0 | 6 | $5.42M | $-5.42M |
| Ashiya Mona | director | 0 | $0 | 7 | $20.11M | $-20.11M |
| ORBIMED ADVISORS LLC | director | 0 | $0 | 7 | $20.11M | $-20.11M |
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.
Over the last 12 months, insiders at Disc Medicine, Inc. have bought $0 and sold $50.32M worth of Disc Medicine, Inc. stock.
On average, over the past 5 years, insiders at Disc Medicine, Inc. have bought $12M and sold $51.61M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 222,223 shares for transaction amount of $8M was made by Bitterman Kevin (director) on 2024‑06‑17.
| 2025-07-17 | Sale | Franchi Jean M. | Chief Financial Officer | 2,031 0.006% | $59.00 | $119,829 | -2.08% | |
| 2025-07-10 | Sale | Franchi Jean M. | Chief Financial Officer | 2,000 0.0057% | $57.50 | $115,000 | +3.33% | |
| 2025-07-09 | Sale | Quisel John D | Chief Executive Officer | 34,800 0.0995% | $55.33 | $1.93M | +2.63% | |
| 2025-07-03 | Sale | Quisel John D | Chief Executive Officer | 5,200 0.0151% | $55.09 | $286,454 | +2.74% | |
| 2025-06-16 | Sale | Franchi Jean M. | Chief Financial Officer | 2,000 0.0058% | $52.26 | $104,519 | +4.41% | |
| 2025-06-06 | Sale | Savage William Jacob | Chief Medical Officer | 2,996 0.0086% | $50.00 | $149,800 | +7.09% | |
| 2025-05-20 | Sale | Savage William Jacob | Chief Medical Officer | 6,677 0.0193% | $50.04 | $334,128 | +4.56% | |
| 2025-05-02 | Sale | Savage William Jacob | Chief Medical Officer | 2,100 0.0061% | $50.17 | $105,367 | +1.95% | |
| 2025-03-24 | Sale | ORBIMED ADVISORS LLC | director | 5,738 0.0167% | $54.11 | $310,483 | -9.23% | |
| 2025-03-24 | Sale | Ashiya Mona | director | 5,738 0.0167% | $54.11 | $310,483 | -9.23% | |
| 2025-03-21 | Sale | ORBIMED ADVISORS LLC | director | 10,011 0.0299% | $54.00 | $540,594 | -6.41% | |
| 2025-03-21 | Sale | Ashiya Mona | director | 10,011 0.0299% | $54.00 | $540,594 | -6.41% | |
| 2025-03-20 | Sale | ORBIMED ADVISORS LLC | director | 2,762 0.0081% | $54.01 | $149,176 | -7.66% | |
| 2025-03-20 | Sale | Ashiya Mona | director | 2,762 0.0081% | $54.01 | $149,176 | -7.66% | |
| 2025-03-19 | Sale | ORBIMED ADVISORS LLC | director | 39,656 0.1153% | $54.02 | $2.14M | -8.04% | |
| 2025-03-19 | Sale | Ashiya Mona | director | 39,656 0.1153% | $54.02 | $2.14M | -8.04% | |
| 2025-03-12 | Sale | ORBIMED ADVISORS LLC | director | 83,182 0.243% | $54.45 | $4.53M | -7.92% | |
| 2025-03-12 | Sale | Ashiya Mona | director | 83,182 0.243% | $54.45 | $4.53M | -7.92% | |
| 2025-03-11 | Sale | ORBIMED ADVISORS LLC | director | 27,056 0.0784% | $54.01 | $1.46M | -7.81% | |
| 2025-03-11 | Sale | Ashiya Mona | director | 27,056 0.0784% | $54.01 | $1.46M | -7.81% |
| ORBIMED ADVISORS LLC | director | 186541 0.5386% | $10.78M | 1 | 7 | +10.7% |
| Ashiya Mona | director | 186541 0.5386% | $10.78M | 1 | 7 | +10.7% |
| Quisel John D | Chief Executive Officer | 161828 0.4672% | $9.35M | 0 | 6 | |
| Stephenson Pamela | Chief Commercial Officer | 69529 0.2008% | $4.02M | 0 | 1 | |
| Franchi Jean M. | Chief Financial Officer | 63499 0.1833% | $3.67M | 0 | 4 | |
| Savage William Jacob | Chief Medical Officer | 56725 0.1638% | $3.28M | 0 | 8 | |
| Yu Jonathan Yen-Wen | Chief Operating Officer | 40555 0.1171% | $2.34M | 0 | 1 | |
| Khara Rahul | Chief Legal Officer | 37583 0.1085% | $2.17M | 0 | 3 | |
| White William Richard | director | 0 0% | $0 | 0 | 10 | |
| AI DMI LLC | 10 percent owner | 3141759 9.0712% | $181.5M | 1 | 0 | +100.92% |
| Bitterman Kevin | director | 420549 1.2143% | $24.3M | 1 | 2 | +10.7% |
| Atlas Venture Fund X, L.P. | 10 percent owner | 198326 0.5726% | $11.46M | 0 | 7 |
$193,151,375 | 134 | 8.18% | $1.84B | |
$21,345,882 | 83 | 94.45% | $1.8B | |
$54,590,806 | 65 | 21.84% | $1.8B | |
$1,376,668 | 53 | 18.46% | $1.78B | |
$150,253,463 | 26 | -52.83% | $2.1B | |
$1,801,511 | 23 | 18.58% | $2.31B | |
$154,554,190 | 14 | 29.60% | $2.32B | |
$137,027,226 | 13 | 28.32% | $1.75B | |
$1,248,715 | 10 | 5.66% | $1.84B | |
$45,445,266 | 9 | -24.96% | $1.89B | |
$32,575,266 | 8 | 37.03% | $1.82B | |
$25,073,947 | 7 | -5.99% | $2.02B | |
$21,792,890 | 6 | 75.72% | $1.76B | |
Disc Medicine, Inc. (IRON) | $24,000,085 | 4 | 33.26% | $2B |
$142,493,653 | 3 | 4.30% | $2.12B | |
$103,599,972 | 2 | -36.81% | $2.33B | |
$49,999,992 | 1 | 50.02% | $2.34B | |
$9,900,000 | 1 | -7.19% | $2.03B | |
$7,600,000 | 1 | -4.05% | $2.04B |
| Increased Positions | 99 | +71.22% | 9M | +33.17% |
| Decreased Positions | 57 | -41.01% | 2M | -8.63% |
| New Positions | 27 | New | 3M | New |
| Sold Out Positions | 24 | Sold Out | 689,318 | Sold Out |
| Total Postitions | 181 | +30.22% | 33M | +24.54% |
| Atlas Venture Life Science Advisors, Llc | $124,243.00 | 7.17% | 2.51M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $103,702.00 | 5.98% | 2.09M | +234,828 | +12.63% | 2025-03-31 |
| Fmr Llc | $92,398.00 | 5.33% | 1.87M | +1M | +358.75% | 2024-12-31 |
| Orbimed Advisors Llc | $88,404.00 | 5.1% | 1.79M | 0 | 0% | 2024-12-31 |
| Frazier Life Sciences Management, L.P. | $86,882.00 | 5.01% | 1.75M | 0 | 0% | 2024-12-31 |
| Paradigm Biocapital Advisors Lp | $74,152.00 | 4.28% | 1.5M | 0 | 0% | 2024-12-31 |
| Wellington Management Group Llp | $69,087.00 | 3.99% | 1.4M | -444,821 | -24.17% | 2024-12-31 |
| Price T Rowe Associates Inc /Md/ | $69,048.00 | 3.99% | 1.39M | +262,690 | +23.21% | 2024-12-31 |
| Janus Henderson Group Plc | $60,294.00 | 3.48% | 1.22M | +467,988 | +62.41% | 2024-12-31 |
| Vanguard Group Inc | $52,889.00 | 3.05% | 1.07M | +18,716 | +1.78% | 2024-12-31 |